iShares Dow Jones U.S. Pharmaceutical Index Fund | TalkMarkets

Latest Posts

A Look At Pharma ETFs After Q4 Earnings

Article By: Sweta Killa

Monday, February 12, 2024 6:40 PM EDT

The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.

In this article: BMY, JNJ, LLY, MRK, PFE, IHE, PJP, PPH, XPH, FTXH

Read

5 Sector ETFs That Outperformed In Turbulent August

Article By: Sweta Killa

Wednesday, August 30, 2023 9:48 AM EDT

Wall Street has lost momentum since the start of August, triggered by the series of bank downgrades and fears of higher rates for a longer-than-expected period.

In this article: XTL, IHE, PXE, PFIX, URNJ

Read

Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts

Article By: Sweta Killa

Friday, August 25, 2023 2:21 PM EDT

While longer-than-expected rate worries and banking concerns led to feeble trading in recent weeks, a few equity ETFs rose or saw a modest decline over the past month.

In this article: IAK, IHE, PXE, XLC, IEDI

Read

Pharma ETFs In Focus Post Q2 Earnings

Article By: Sweta Killa

Saturday, August 12, 2023 7:30 AM EDT

Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth.